Independent investigator grant study-comparative effects of chronic treatment with olanzapine and risperidone on glucose and lipid metabolism.

Trial Profile

Independent investigator grant study-comparative effects of chronic treatment with olanzapine and risperidone on glucose and lipid metabolism.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Oct 2012

At a glance

  • Drugs Olanzapine (Primary) ; Risperidone
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Jul 2010 Results have been published in Schizophrenia Research.
    • 01 Nov 2009 Results published in the Journal of Clinical Psychiatry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top